(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 1. Abnormal skin development and Wnt/β-catenin pathway
activation in stabilized β-catenin mutant embryos.
(A-H) Control littermate and KRT14-Cre
Ctnnb1(Ex3)fl/+ (Act β-catenin) embryos at the stages
indicated. Arrows indicate keratinized plaques in mutant embryos.
(I,J) Higher magnification views of dorsal skin from G and H,
respectively. Pigment (arrows) accumulates in mutant skin. (K,L)
Immunohistochemistry for β-catenin at E15.5 showing elevated
β-catenin levels in control placodes (K), and cytoplasmic and nuclear
β-catenin throughout mutant ectoderm (L, arrows). (M-P)
X-gal-stained control BATgal (M,O) and KRT14-Cre
Ctnnb1(Ex3)fl/+ BATgal (Act β-catenin
BATgal) (N,P) littermates at E13.5 (M,N) and E16.5 (O,P), showing
increased BATgal expression and its irregular pattern in the mutant.
Scale bar in L applies to K and L.